Navigation Links
Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2013
Date:7/25/2013

NEW YORK, July 25, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2013

http://www.reportlinker.com/p0910506/Peripheral-Neuropathy-Sensory-Neuropathy-Global-Clinical-Trials-Review-H1-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

 

Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2013

 

Summary

 

GlobalData's clinical trial report, "Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2013" provides data on the Peripheral Neuropathy (Sensory Neuropathy) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Peripheral Neuropathy (Sensory Neuropathy). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Peripheral Neuropathy (Sensory Neuropathy). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

 

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Scope

 

- Data on the number
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovios Electroporation Technology Provides Significant Therapeutic Effects for Peripheral Arterial Disease in Animal Model
2. Peripheral Vascular Devices Market (Peripheral Vascular Stents, PTA Balloon Catheters, Guidewires, IVC Filters, Atherectomy, Chronic Total Occlusion, Embolic Protection Devices, Synthetic Surgical Grafts, Aortic Stents) - Global Industry Analysis, S
3. QualiMed Innovative Medizinprodukte GmbH, Based in Winsen Germany has Received Notice of CE Approval for its Line of Peripheral Balloons for the Treatment of Peripheral Vascular Obstructions
4. US Peripheral Vascular Device Market to Grow Strongly to $3.3 Billion by 2017
5. Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Manufacturers
6. Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy
7. Anesthesia Equipment and Associated Peripherals: Advanced, Patient-Friendly Devices Will Sustain Market Growth in Europe, States Frost & Sullivan
8. Peripheral Vascular Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
9. Global Peripheral Vascular Devices Market 2011-2015
10. Brazil Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others
11. North America Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology Prosthetic Heart Valves and Others
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... VANCOUVER, British Columbia and ... DelMar Pharmaceuticals, Inc. (OTCQX: ... focused on developing and commercializing proven cancer therapies ... data at the American Association of Cancer ... on the potential for its lead product ...
(Date:5/29/2015)...  Eli Lilly and Company (NYSE: LLY ) ... they have entered into a clinical trial collaboration to ... anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination with CYRAMZA ... medicine. The planned study will assess the combination as ... The Phase I study is expected to establish ...
(Date:5/29/2015)... 2015  World-renowned prostate surgeon and New York Urologist, Dr. ... of MR/Ultrasound Fusion-Guided Biopsy for detecting aggressive ... Center at Lenox Hill Hospital is the only center ... New York City . We,ve seen tremendous improvement ... The use of an MRI makes for a much more ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2
... UK pharma group GlaxoSmithKline reports a 2% ... underlying sales momentum. In an interview with ... CFO Simon Dingemans review Q2 results including overall delivery ... a review of the recently implemented Drug Performance Units. ...
... Pharmaceuticals, Inc. announced the following news today concerning the future ... On December 31, 2011, the FDA ban ... a propellant will become effective. Primatene® Mist has ... symptoms for over 40 years. The ban on the sale ...
Cached Medicine Technology:Statement on Availability of Primatene® Mist CFC 2
(Date:5/30/2015)... 2015 The IRS released an ... that, “criminals used taxpayer-specific data acquired from non-IRS sources ... tax accounts through IRS’ “Get Transcript” application. This data ... address.” , “You don’t even have to be ... it was only a matter of time, especially after ...
(Date:5/29/2015)... May 30, 2015 “In the ... local and federal regulations, we provide education that ... patients who are suffering from pain, within the ... Nalamachu, MD, professor of rehabilitation medicine and President/Medical ... Overland Park, Kansas. , A new flight of ...
(Date:5/29/2015)... Tallahassee, FL (PRWEB) May 29, 2015 Ready ... trip, it’s important for all drivers to get their vehicles ... do to be prepared. Advanced Driving Systems (ADS) is ready ... some tips on preparing for summer road trips. , When ... do the following to ensure that the trip goes smoothly ...
(Date:5/29/2015)... May 29, 2015 The science of ... Los Angeles thanks to the efforts of internationally recognized ... has combined ARTAS hair restoration and manual ... restoration procedures available anywhere. , A Follicular Unit ... individually harvesting hair follicle grafts from the donor areas ...
(Date:5/29/2015)... Island (PRWEB) May 29, 2015 The ... 2015. The event, now closed to new registration, starts ... Adams. This exciting competitive running event demonstrates the ... to create a public benefit – in this case, ... coastal views around the famed Ocean Drive and passes ...
Breaking Medicine News(10 mins):Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 2Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 3Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 4Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 5Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 3Health News:Los Angeles and Beverly Hills Hair Transplant Doctor Now Combines Robotic Hair Restoration (ARTAS) and Manual FUE Transplants for Maximum Hair Coverage 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 3
... of the communicable diseases in the country, according to ... Health and Family Welfare//. The news report was released ... a village near Vriddachalam. Chidambaram MP, E Ponnusamy, MLAs ... function. ,As many as 60 government doctors, ...
... UNICEF would collaborate on spreading awareness regarding the transmission ... spreading awareness to young people the dangers of HIV ... as children’s and young people are more attracted towards ... Understanding was signed in Delhi in the presence of ...
... is an idiopathic inflammatory disorder of the ... remain incompletely understood, many experimental and clinical ... in its pathogenesis//. ,In genetically ... failure of normal regulatory constraints on the ...
... of Delaware have developed a unique nanobomb that can ... more specifically breast cancer cells//. ,This latest attack ... and Oncology Issues by Balaji Panchapakesan, assistant professor of ... that the nanobomb technology is still in its infancy ...
... Immunodeficiency Virus type 1 (HIV-1) infection has improved ... 1996//. More recently, new drugs have been approved, ... while some previously popular drugs are being used ... Resistance testing is used more commonly in clinical ...
... have found an active gene in the legs of fleas, ... the flea to jump and leap at incredible heights and ... an incredible speed of 200 times/second. , ,Scientists have ... cultured them in the bacteria E.coli and found that it ...
Cached Medicine News:Health News:Non-Communicable Diseases Mounting Up At An Alarming Rate in India 2Health News:Indian Olympic Association And UNICEF To Collaborate On HIV/AIDS Awareness 2Health News:Bifidogenic Growth Stimulator: A Non-Toxic Way To Treat Ulcerative Colitis 2Health News:Simplest therapeutic regimen found less effective against HIV 2Health News:Resilin Protein from Flea can be used for cardiovascular disease 2
Inquire...
The Perfect Single basic Vac Manifold is used to process a single 96-well plate; processing time is approximately 30 minutes....
The Perfect Vac Quad Manifold allows one to four 96-well plates to be processed simultaneously. A single plate may be processed in 30 minutes; four plates are processed in 45 minutes....
... from Caliper provide an automated alternative to Kuderna-Danish, Rotary, Vacuum-Style and Nitrogen Blow-Down Evaporators. For over ten ... today. ... ... ...
Medicine Products: